je.st
news
Home
›
Biotech Leader Testifies at Congressional Hearing on Legislative Proposals to Enhance Capital ...
Biotech Leader Testifies at Congressional Hearing on Legislative Proposals to Enhance Capital ...
2014-04-09 06:00:00| Industrial Newsroom - All News for Today
The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled "Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies." Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market. This story is related to the following:Trade Associations
Tags: capital
leader
enhance
hearing
Category:Industrial Goods and Services